ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 251682 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 251682; 2) Community: the network communities that were significantly associated with the response to NSC 251682; 3) Molecule: the relationships between components within communities and NSC 251682; 4) MDR: the compounds that were significantly associated with the NSC 251682.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.00640068043275774 0.32445093
NSC 711077 Null 0.00640068043275774 0.11825551
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00640068043275774 0.26799365
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.00640068043275774 0.26936701
NSC 725098 Null 0.00640068043275774 0.045992611
NSC 726217 Combretastatin A4-analogue 0.00640068043275774 0.13172834
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.00640068043275774 0.2222214
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.00640068043275774 0.17117103
NSC 744688 Null 0.00640068043275774 0.15952853
NSC 751042 Null 0.00640068043275774 0.30013021
Total:116  Current:21    [First] [Prev] [Next] [Last]